This round was led by Fortissimo Capital, with participation from existing investors. The newly secured capital will fuel commercial expansion and accelerate the innovation of new products that leverage Scopio's Full-Field technology. This Series D brings Scopio's total fundraising to $130M.

Scopio Labs is the developer of Full-Field imaging fueling the digital transformation of hematology laboratories worldwide. By supporting laboratory scientists and clinicians with unprecedented scale and depth in digital cell morphology, the company's platforms enable timely detection of blood-related medical conditions, expediting patients' access to life-saving treatments. Scopio solves cell morphology's age-old trade-off between resolution and field of view. Its high-resolution imaging and embedded AI combine for more efficient remote workflow, contributing to better diagnostics across the continuum of care.